MedPath

Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam Capsule

Not Applicable
Completed
Conditions
Angiodysplasia
Méléna
Gastrointestinal Bleedings
Polyps
Anemia
Interventions
Device: capsule endoscopies
Registration Number
NCT01820182
Lead Sponsor
Hôpital Edouard Herriot
Brief Summary

Comparative, randomized study patients are scheduled to have two capsule endoscopies within 2 to 14 days from each other using two different endoscopies the Pillcam SB2 (Given Imaging, Israel) and the Capsocam (Capso Vision Saratoga United States) The order in which the devices are administered is randomly allocated.

Detailed Description

Objectives

Main objective

To compare the diagnostic yield of both capsules in the same patients with a satisfying concordance coefficient k\>0,6

Secondary objectives

To compare the sensitivity and specificity of both capsule readings To copmpare the sensitivity and specificity for specific lesions classified in terms of relevance P0 P1 P2 To check the tecnical fiability (incidence of technical issues To check the feasibility To evaluate the rate of complete small bowel examination, the small bowel transit time the capsule reading time

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
73
Inclusion Criteria
  • over 18 years old
  • obscure digestive bleeding justifying capsule endoscopy
  • complete endoscopic work up including colonoscopy with ileoscopy and gastroscopy with aneathesia or sedation
  • absence of concomittent ongoing study
  • absence of occlusive symptoms of suspected Crohn's disease nor of previous small bowel radiotherapy
  • filled inform consent
  • no implanted pace maker
  • patient being affiliated to the CPAM
Exclusion Criteria
  • under 18 years old
  • oral iron within 8 days before capsule endoscopy
  • gastroparesis
  • pacemaker
  • swallowing troubles
  • presence of oclusive symptoms suspected Crohn's disease nor of previous small bowel radiotherapy
  • pregnancy or risk of pregnancy without efficient oral contraception
  • absence of written informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
capsocam capsulacapsule endoscopiescapsocam capsula readings
Primary Outcome Measures
NameTimeMethod
number of discordant films between the two capsules with two different readers14 days

Reading of the two capsules film is randomized order by two different readers in each center

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath